Lipoprotein(a) and other risk factors in dyslipidemic patients with and without heart failure
Introduction Material and methods Results Conclusions
Saved in:
| Main Authors: | Joanna Lewek, Bozena Sosnowska, Agata Bielecka-Dabrowa, Karina Mierczak, Weronika Adach, Maciej Banach |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-10-01
|
| Series: | Archives of Medical Science |
| Online Access: | https://www.archivesofmedicalscience.com/Lipoprotein-a-and-other-risk-factors-in-dyslipidemic-patients-with-and-without-heart,194684,0,2.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.
by: Bożena Sosnowska, et al.
Published: (2025-02-01) -
Cmpk2 Gene and Protein Expression in Saliva or Salivary Glands of Dyslipidemic Mice
by: Baiyan Zhang, et al.
Published: (2024-12-01) -
Inflammation but Not Endothelial Dysfunction Is Associated with the Severity of Coronary Artery Disease in Dyslipidemic Subjects
by: Christian F. Rueda-Clausen, et al.
Published: (2009-01-01) -
Rosuvastatin-based combination treatment with acetylsalicylic acid or ezetimibe in the management of patients at high and very high cardiovascular risk. Expert opinion paper of the Polish Lipid Association 2025
by: Maciej Banach, et al.
Published: (2025-01-01) -
Editorial: Therapeutic strategies to lower residual dyslipidemic CV risk beyond LDL-C and statins
by: Raffaele De Caterina, et al.
Published: (2025-06-01)